home / stock / phas / phas short
Short Information | PhaseBio Pharmaceuticals Inc. (NASDAQ:PHAS)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 12,792,016 |
Total Actual Volume | 77,583,264 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 639,601 |
Average Short Percentage | 18.37% |
Is there a PHAS Short Squeeze or Breakout about to happen?
See the PHAS Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
11-02-2022 | $0.0807 | $0.0701 | $0.092 | $0.0665 | 8,640,505 | 1,005,188 | 11.63% |
11-01-2022 | $0.125 | $0.095 | $0.125 | $0.0768 | 27,002,948 | 4,360,020 | 16.15% |
10-31-2022 | $0.1112 | $0.1034 | $0.126 | $0.099 | 4,902,182 | 832,685 | 16.99% |
10-28-2022 | $0.1398 | $0.107 | $0.1398 | $0.101 | 3,652,517 | 916,969 | 25.11% |
10-27-2022 | $0.1215 | $0.1318 | $0.144 | $0.1211 | 3,225,450 | 480,220 | 14.89% |
10-26-2022 | $0.1271 | $0.1217 | $0.1348 | $0.1211 | 4,451,417 | 498,317 | 11.19% |
10-25-2022 | $0.1549 | $0.135 | $0.1549 | $0.13 | 9,877,958 | 1,227,701 | 12.43% |
10-24-2022 | $0.1805 | $0.1409 | $0.2091 | $0.12 | 7,517,527 | 1,914,341 | 25.47% |
10-21-2022 | $0.199 | $0.1981 | $0.2 | $0.1878 | 348,377 | 50,457 | 14.48% |
10-20-2022 | $0.191 | $0.1976 | $0.2024 | $0.1899 | 283,414 | 57,473 | 20.28% |
10-19-2022 | $0.21 | $0.1904 | $0.21 | $0.188 | 295,463 | 88,754 | 30.04% |
10-18-2022 | $0.2005 | $0.195 | $0.2058 | $0.1856 | 574,933 | 117,437 | 20.43% |
10-17-2022 | $0.214 | $0.197 | $0.214 | $0.1906 | 424,119 | 74,320 | 17.52% |
10-14-2022 | $0.201 | $0.2076 | $0.225 | $0.1938 | 783,653 | 151,991 | 19.4% |
10-13-2022 | $0.1884 | $0.201 | $0.204 | $0.181 | 1,440,150 | 240,908 | 16.73% |
10-12-2022 | $0.1811 | $0.1905 | $0.195 | $0.18 | 947,423 | 198,699 | 20.97% |
10-11-2022 | $0.189 | $0.1811 | $0.19 | $0.18 | 470,748 | 98,181 | 20.86% |
10-10-2022 | $0.2 | $0.1817 | $0.2 | $0.1811 | 1,358,601 | 227,967 | 16.78% |
10-07-2022 | $0.195 | $0.1819 | $0.195 | $0.18 | 539,581 | 94,689 | 17.55% |
10-06-2022 | $0.18 | $0.1933 | $0.2 | $0.177 | 846,298 | 155,699 | 18.4% |
News, Short Squeeze, Breakout and More Instantly...
PhaseBio Pharmaceuticals Inc. Company Name:
PHAS Stock Symbol:
NASDAQ Market:
Bidding Process and Auction Projected to Conclude December 2022 PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular diseases, today announced that...
PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular diseases, today reported financial results for the second quarter ended June 30, 2022, and provided an upd...